[ad_1]
By IOL Reporter 
2h ago
Cape Town: in the last 24 hours, a total of 3,105 new cases related to Covid-19 have been identified in the country.
This brings the cumulative total of Covid-19 cases to 762,763, Health Minister Zweli Mkhize said in a statement on Friday.
” We wish to highlight that we have surpassed the 3,000 new cases daily mark (2,500 new cases were identified on Thursday and 2,888 on Friday). Of these new cases, more than half (54.4%) are from the Eastern Cape, ”said Mkhize.
” We are also concerned that the positivity is 12%, which is higher than ideal, that is, 10% or less.
Sadly, 88 more Covid-19-related deaths have been reported: Eastern Cape 67, Free State 15, Gauteng 2, KwaZulu-Natal 1, and Western Cape 3.
This brings the total to 20,759 deaths. We have noticed that the number of new deaths being reported daily in the Eastern Cape is also increasing. ”
“We extend our condolences to the loved ones of the deceased and thank the health workers who treated the deceased patients.”
The number of recoveries now stands at 707,040, which translates into a recovery rate of 92.7%. The cumulative number of tests performed to date is 5,243,055, with 29,019 new tests performed since the last report.
The Proteas cricket team has been rocked by another positive test for Covid-19, the second on the team after the mandatory second round of Covid-19 testing.
The player, who has not been identified due to medical / patient confidentiality, tested positive Thursday and was separated from the team.
Transport Minister Fikile Mbalula tested negative for Covid-19 after a health problem this week.
Mbalula said on Twitter that she got tested for coronavirus after feeling unwell since Monday.
“(I) have not felt well since Monday. My test for Covid-19 (and the) results were negative, ”he said.
Meanwhile, Gilead’s remdesivir should not be used in hospitalized Covid-19 patients, regardless of how ill they are, as there is no evidence that the drug improves survival or reduces the need for ventilation, a panel of experts said Friday. World Health Organization.
“The panel found a lack of evidence that remdesivir improved outcomes that are important to patients,” the guideline said.
“Especially given the costs and resource implications associated with remdesivir … the panel felt that the onus should be on demonstrating evidence of efficacy, which is not established by the currently available data.”
MESS
[ad_2]
